The slip
PARKINSON RECEIPTno. 4370
20 Oct 2026, 15:58 UTCdopamine neurons, braak
predictionFKRP in dopamine neurons tracks Braak Lewy-body stage
registeredfb66ad0c07288212
discovery-0.32 p=0.407 n=9
replication-0.25 p=0.508 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.32, p 0.407)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT13c8213cf4f5ef05dbce1db2…
follows 7b234ee78529…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4370: FKRP in dopamine neurons, braak
- power
- full sample -0.30 (p 0.232, n 18), 95% CI -0.67 to +0.20. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.29 (p 0.246, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.31 (p 0.211, n 18). could be the mix.
- skeptic
- leave-one-out range -0.39 to -0.19, sign flips 0; without severely affected donors -0.30 (p 0.232, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.66 (p 0.0028, n 18) vs -0.30 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FKRP in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up FKRP · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.75 p 0.0077 (needs p < 4.5e-4)